Education
About Us
Working with TipRanks
Follow Us
LB Pharmaceuticals, Inc. (LBRX)
NASDAQ:LBRX
| Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -64.83M | $ -11.38M | $ -2.81M |
| EBITDA | $ -63.01M | $ -1.45M | $ -12.19M |
| Net Income | $ -63.10M | $ -6.28M | $ -14.35M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 28.00M | $ 43.29M | $ 21.40M |
| Total Assets | $ 33.53M | $ 45.66M | $ 21.49M |
| Total Debt | $ 3.70M | $ 0.00 | $ 24.15M |
| Net Debt | $ -19.27M | $ -14.98M | $ 2.74M |
| Total Liabilities | $ 128.09M | $ 80.13M | $ 50.30M |
| Stockholders' Equity | $ -94.55M | $ -34.47M | $ -28.81M |
| Cash Flow | |||
| Free Cash Flow | $ -53.82M | $ -12.12M | $ -2.73M |
| Operating Cash Flow | $ -53.05M | $ -12.09M | $ -2.73M |
| Investing Cash Flow | $ 23.23M | $ -28.01M | $ 123.00K |
| Financing Cash Flow | $ 38.31M | $ 33.68M | $ 22.96M |